Many countries struggle to provide citizens with affordable access to medicines. Often, this situation stems from a lack of reliable information on—and accountability in the medicines market for—the price, availability, affordability, quality and promotion of medicines.
The Medicines Transparency Alliance (MeTA) offers a novel approach for low- and middle-income countries to address transparency and accountability issues. In MeTA, each of the seven participating countries (Ghana, Jordan, Kyrgyzstan, Peru, the Philippines, Uganda and Zambia) have established their own MeTA councils—a multi-stakeholder group of representatives from the public and private sectors and civil society. Each in-country council identifies national health policy priorities and collects, shares and analyses data on the selection, procurement, quality, availability, pricing, promotion and use of medicines. They then use this information to inform—and improve—national medicines policy.
Health Action International and the World Health Organization are the international secretariat for the MeTA programme. The programme is funded by the United Kingdom Government’s Department for International Development.